Harvard Medical School Professor Announces a Natural Alternative to the Traditional Flu Shot
BOSTON -- In response to the critical shortage of flu vaccine, Dr. Jack Bukowski, assistant clinical professor of Medicine at Harvard Medical School and Brigham and Women's Hospital in Boston announced today a safe, natural alternative for those unable to get a traditional flu shot.
Bukowski's research has lead to the formulation of an immune system booster containing L-theanine, a substance found in tea that increases the immune system's ability to fight bacteria and viruses such as influenza by up to 500 percent. No other natural substance has ever been clinically shown to boost this critical part of the human immune system.
In a recent interview, Bukowski stated that L-theanine is broken down
in the liver to ethylamine, a molecule that primes the response of an immune
blood cell called the gamma-delta T cell.
"We know from other studies that
these gamma-delta T cells in the blood are the first line of defense against
many types of bacterial, viral, fungal and parasitic infections. They also
have anti-tumor activity. These gamma-delta T cells secrete interferon, a key
part of the body's chemical defense against infection. Studies using mice
given human immune systems show that if you boost this part of the immune
system it can significantly protect against infection."
Flu shots work by boosting the portion of your immune system that fights
off one specific type of influenza virus. By naturally boosting the immune
systems function the body's ability to fight many kinds of flu and even the
onset of the common cold is dramatically increased.
Source: Infotv, Inc.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
